XSHE
301580
, Last price
Name
Aidite Qinhuangdao Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aidite (Qinhuangdao) Technology Co., Ltd. is a key player in the research, development, production, and commercialization of advanced zirconia materials for dental applications. The company offers a comprehensive suite of dental solutions under its 'Cameo' brand. This extensive portfolio encompasses cutting-edge materials like Cameo 3D instant restorative zirconia and Cameo glass ceramics, alongside essential equipment. These include the Cameo intraoral scanner, the Cameo N4 and AV-D5 milling machines (with specialized systems for dry zirconia milling via the AV-D5 and wet glass ceramics milling via the N4), as well as Cameo fast sintering and glaze furnaces, providing a complete workflow for dental professionals. Established on March 15, 2007, by co-founders Hong Wen Li and Bin Li, the enterprise is headquartered in Qinhuangdao, China.
Headquarters & legal address
河北省秦皇岛市经济技术开发区都山路9号
秦皇岛市, HE 050000
CN
秦皇岛市, HE 050000
CN
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |